Table 1.
Clinical parameters | Value | (N) % |
---|---|---|
Age (years) | 64.8 ± 9.3 | |
Males | (63) 86 | |
Systolic blood pressure (mm Hg) | 120.5 ± 10.2 | |
Heart rate (bpm) | 70.6 ± 13.2 | |
Arterial hypertension | (50) 68 | |
Diabetes % | (28) 38 | |
COPD | (24) 32 | |
Chronic kidney disease (%) | (13) 18 | |
Atrial fibrillation (%) | (27) 37 | |
LVEF (%) | 33.1 ± 6.3 | |
LV end-diastolic diameter (mm) | 62.8 ± 7.7 | |
LA diameter (mm) | 45.8 ± 6.2 | |
Creatinine (mg/dl) | 1.15 ± 0.42 | |
Serum potassium (mEq/L) | 4.48 ± 0.48 | |
NTproBNP | 628.4 ± 3089.2 | |
Drug therapy | (N) % | |
Beta-blockers | (70) 96 | |
Furosemide | (59) 81 | |
Spironolactone | (46) 63 | |
Ivabradine | (25) 34 | |
Digoxin | (2) 3 | |
Amiodarone | (30) 41 | |
Aspirin | (41) 56 | |
OAC | (32) 44 |